The firm will evaluate the combination therapy in 80 patients with germline BRCA1/2-mutated HER2-negative locally advanced or metastatic breast cancer.
The VERVE-102 base editor appeared to be safe and reduce low-density lipoprotein cholesterol levels by up to 62 percent in a Phase 1 open-label, single-ascending dose trial.
The task force that makes recommendations on cancer screening, including genetic testing, hasn't met since March 2025 but ...
Datroway gained US approval for first-line TNBC patients while Enhertu was recommended for approval in Europe as a tissue-agnostic treatment for HER2-positive tumors.
The EMA accepted Regeneron's marketing authorization application for the gene therapy and will review it under accelerated assessment.
The partners will stop developing BIIB122 in an all-comer population, but Denali will keep evaluating it in those with LRRK2 pathogenic variants.
The recommendation, based on data from the SERENA-6 trial, breaks from the opinion of an FDA advisory committee last month.
Foundation Medicine previously received companion diagnostic approval for its FoundationOne Liquid CDx assay alongside EMD Serono's Tepmetko.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results